Collaboration Agreements (Details) - Neurocrine Biosciences [Member] - License and Collaboration Agreement [Member] $ in Thousands	12 Months Ended
	Dec. 31, 2025 USD ($)
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Potential milestone payments receivable	$ 1,667,500
Percentage of option to co-fund development costs upon achievement of certain milestones	50.00%
Milestone revenue	$ 7,500
Regulatory Milestone [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Potential milestone payments receivable	1,067,500
Sales Based Milestone [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Potential milestone payments receivable	$ 600,000